Piramal Enterprises Ltd
NSE:PEL
Piramal Enterprises Ltd
Note Receivable
Piramal Enterprises Ltd
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Piramal Enterprises Ltd
NSE:PEL
|
Note Receivable
₹598.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
46%
|
|
|
Housing and Urban Development Corporation Ltd
NSE:HUDCO
|
Note Receivable
₹1.1T
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
REC Limited
NSE:RECLTD
|
Note Receivable
₹5.6T
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Power Finance Corporation Ltd
NSE:PFC
|
Note Receivable
₹10.2T
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Indian Railway Finance Corp Ltd
NSE:IRFC
|
Note Receivable
₹4.4T
|
CAGR 3-Years
6%
|
CAGR 5-Years
126%
|
CAGR 10-Years
N/A
|
|
|
I
|
Indian Renewable Energy Development Agency Ltd
NSE:IREDA
|
Note Receivable
₹755.4B
|
CAGR 3-Years
29%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Piramal Enterprises Ltd
Glance View
Piramal Enterprises Ltd. stands as a testament to strategic evolution within India's business landscape. Originating as a textile business in the 1980s, the company has undergone a dramatic transformation under the visionary leadership of Ajay Piramal. Transitioning from textiles, Piramal Enterprises repositioned itself in the healthcare sphere, marking significant milestones through strategic acquisitions. However, most notably, Piramal's foray into the healthcare and pharmaceutical industry leveraged both organic growth and targeted acquisitions, establishing it as a formidable player on the global stage. By focusing on high-quality and innovative solutions, Piramal offers products across a spectrum of sectors including critical care, healthcare insights, and analytics, all the while maintaining strong global partnerships which have amplified its reach and market presence. Diversification remains a cornerstone of Piramal's business model as it extends beyond its healthcare roots into the financial services realm. The company's financial services arm encompasses a variety of avenues such as lending, distressed asset investment, and real estate funding, illustrating its adeptness at identifying and capitalizing on market opportunities. By marrying robust governance with a keen understanding of market dynamics, Piramal Enterprises ingeniously leverages its strengths in both its primary markets. With a deliberate focus on achieving operational efficiency and strategic clarity, Piramal sustains its growth trajectory while ensuring long-term value creation for its stakeholders, showcasing resilience and adaptability in an ever-evolving economic environment.
See Also
What is Piramal Enterprises Ltd's Note Receivable?
Note Receivable
598.9B
INR
Based on the financial report for Dec 31, 2024, Piramal Enterprises Ltd's Note Receivable amounts to 598.9B INR.
What is Piramal Enterprises Ltd's Note Receivable growth rate?
Note Receivable CAGR 10Y
46%
Over the last year, the Note Receivable growth was 20%. The average annual Note Receivable growth rates for Piramal Enterprises Ltd have been 4% over the past three years , 14% over the past five years , and 46% over the past ten years .
You don't have any saved screeners yet